ACADEMIA
Less than Half of Japan Prefectures Offer SMA Test under Newborn Screening Program: Survey
Fewer than half the number of prefectures in Japan test newborns for spinal muscular atrophy (SMA) under their neonatal mass screening program, according to a recent survey by the Japan Association of Obstetricians and Gynecologists (JAOG). The survey conducted in…
To read the full story
Related Article
ACADEMIA
- Arava Safety Backup at Risk as Questran Supply Falters on Nitrosamine Issue
May 11, 2026
- NCC Launches First Japan Trial for CP Inhibitor-Related Liver Dysfunction
April 27, 2026
- Dementia Drugs See Modest Uptake in Japan amid Eligibility Limits, Safety Concerns
April 9, 2026
- Cancer Drug Supply Risks Spur Calls for Pricing Reform: JSMO
March 31, 2026
- Japan Ophthalmology Society Flags Off-Label Concerns Ahead of Upneeq Launch
March 30, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





